NCT00719914View on ClinicalTrials.gov

A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks

PHASE2TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

January 31, 2009

Conditions
ST-Elevation Myocardial Infarction
Interventions
DRUG

eptifibatide

Intra-coronary injection, weight based, of eptifibatide.

DRUG

eptifibatide

Intra-coronary injection, based on weight, of eptifibatide

DRUG

normal saline

Intra-coronary injection, weight based, of normal saline.

Trial Locations (3)

32174

Cardiology Research Associates, Ormond Beach

44906

Mid Ohio Heart Clinic, Mansfield

48307

Crittenton Hospital Medical Center, Rochester

Sponsors

Collaborators (1)

Schering-Plough
All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT00719914 - A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks | Biotech Hunter | Biotech Hunter